Sandra Kraljević Pavelić Selected Research

Sandra Kraljević Pavelić Research Topics

Disease

15	Neoplasms (Cancer) 10/2021 - 12/2009
4	Carcinoma (Carcinomatosis) 11/2021 - 06/2012
3	Osteoporosis 01/2022 - 01/2021
3	Adenocarcinoma 12/2021 - 03/2020
3	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 01/2017
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 10/2020
2	Melanoma (Melanoma, Malignant) 10/2021 - 09/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 08/2019
2	Myocardial Infarction 01/2021 - 08/2019
2	Squamous Cell Carcinoma of Head and Neck 03/2018 - 03/2017
2	Neoplasm Metastasis (Metastasis) 10/2016 - 07/2014
1	Metabolic Bone Diseases (Osteopenia) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Adenocarcinoma of Lung 11/2021
1	COVID-19 04/2021
1	Infections 04/2021
1	Pain (Aches) 01/2021
1	Dysbiosis 11/2020
1	HIV Infections (HIV Infection) 09/2019
1	Anterior Wall Myocardial Infarction 08/2019
1	Oral Lichen Planus 03/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017
1	Fibrosarcoma 11/2017
1	Laryngeal Neoplasms (Laryngeal Cancer) 10/2016
1	Carcinogenesis 10/2016
1	Macular Degeneration (Age-Related Maculopathy) 09/2015
1	Retinal Diseases 09/2015

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2009
4	Cytostatic AgentsIBA 11/2021 - 06/2012
4	Fluorouracil (Carac)FDA LinkGeneric 10/2020 - 01/2017
3	ZeolitesIBA 01/2022 - 01/2021
3	clinoptiloliteIBA 01/2022 - 01/2021
3	sphingosine kinaseIBA 10/2021 - 01/2017
3	pyrimidineIBA 11/2017 - 07/2014
3	Biomarkers (Surrogate Marker)IBA 09/2015 - 07/2014
2	CoumarinsIBA 11/2021 - 09/2012
2	VemurafenibIBA 10/2021 - 06/2021
2	SphingolipidsIBA 10/2021 - 01/2017
2	NucleophosminIBA 10/2021 - 06/2021
2	Pharmaceutical PreparationsIBA 11/2020 - 01/2017
2	BiglycanIBA 03/2018 - 09/2015
2	LumicanIBA 03/2018 - 09/2015
2	Antineoplastic Agents (Antineoplastics)IBA 11/2017 - 12/2009
2	Phosphotransferases (Kinase)IBA 10/2017 - 01/2017
2	ProteomeIBA 09/2015 - 05/2015
2	p38 Mitogen-Activated Protein KinasesIBA 01/2015 - 01/2012
2	EnzymesIBA 09/2014 - 06/2012
2	purineIBA 09/2012 - 06/2012
1	MetalsIBA 01/2022
1	CalciumIBA 01/2022
1	CopperIBA 01/2022
1	SodiumIBA 01/2022
1	MineralsIBA 01/2022
1	benzothiazoleIBA 12/2021
1	ImidazolinesIBA 12/2021
1	compound 20IBA 11/2021
1	Pentamidine (NebuPent)FDA LinkGeneric 11/2021
1	quinolineIBA 11/2021
1	amidoximeIBA 11/2021
1	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 10/2021
1	AntibodiesIBA 04/2021
1	VaccinesIBA 04/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 10/2020
1	AGARIKON. 1IBA 10/2020
1	CytokinesIBA 10/2020
1	Vascular Endothelial Growth FactorsIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	6-chloropurineIBA 03/2020
1	Vitamin D FDA LinkGeneric 08/2019
1	25-hydroxyvitamin DIBA 08/2019
1	Vitamin D-Binding ProteinIBA 08/2019
1	hydroxide ionIBA 08/2019
1	Annexin A5IBA 12/2018
1	Leucine (L-Leucine)FDA Link 03/2018
1	Proteoglycans (Proteoglycan)IBA 03/2018
1	BenzothiazolesIBA 01/2018
1	BenzimidazolesIBA 01/2018
1	Cyclin-Dependent Kinase 9IBA 11/2017
1	Cyclin TIBA 11/2017
1	Mitogen-Activated Protein KinasesIBA 11/2017
1	SphingosineIBA 10/2017
1	OsteopontinIBA 10/2017
1	Phenol (Carbolic Acid)FDA Link 10/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2017
1	polysialic acidIBA 03/2017
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 03/2017
1	Acid CeramidaseIBA 01/2017
1	TriazolesIBA 01/2017
1	Biological ProductsIBA 01/2017
1	src-Family KinasesIBA 10/2016
1	Microfilament Proteins (Actin Binding Proteins)IBA 10/2016
1	IntegrinsIBA 10/2016
1	Singlet OxygenIBA 09/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2016

Therapy/Procedure

10	Therapeutics 01/2022 - 12/2009
1	Drug Therapy (Chemotherapy) 01/2022
1	Photochemotherapy (Photodynamic Therapy) 09/2016